| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3UAA36FHF1 |
| InChI Key | PJTGSIKANITYOO-RCOXNQKVSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H33F3N6O3S |
| Molecular Weight | 542.63 |
| AlogP | 2.84 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 107.53 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 37.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | C-C chemokine receptor type 2 antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 74 | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Chemokine receptor
CC chemokine receptor
|
- | 0 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neuralgia | 2 | D009437 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4457723 |
| FDA SRS | 3UAA36FHF1 |